Horizon Therapeutics Public Ltd Co

BARCLAYS PLC

Report date

9/30/2023

Quarter

2023 Q3

Filed

3/26/2026

Shares

699,553

Value ($000)

80,931

Weight

0.1%

2019 Q4 - 2023 Q3 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	3/26/2026	80,931	0.1%	699,553	9/30/2023
2023 Q2	3/30/2026	100,710	0.1%	979,194	6/30/2023
2023 Q1	3/30/2026	168,866	0.2%	1,547,244	3/31/2023
2022 Q4	3/30/2026	86,243	0.1%	757,849	12/31/2022
2022 Q3	11/3/2022	238,420	0.3%	3,852,296	9/30/2022
2022 Q2	8/12/2022	23,005	0.0%	288,445	6/30/2022
2022 Q1	5/16/2022	60,620	0.0%	576,173	3/31/2022
2021 Q4	2/14/2022	16,910	0.0%	156,908	12/31/2021
2021 Q3	11/9/2021	21,061	0.0%	192,271	9/30/2021
2021 Q2	8/13/2021	19,582	0.0%	209,122	6/30/2021
2021 Q1	5/13/2021	15,445	0.0%	167,813	3/31/2021
2020 Q4	2/11/2021	7,001	0.0%	95,718	12/31/2020
2020 Q3	11/12/2020	359	0.0%	4,623	9/30/2020
2020 Q2	8/12/2020	449	0.0%	8,077	6/30/2020
2020 Q1	5/13/2020	282	0.0%	9,540	3/31/2020
2019 Q4	2/10/2020	987	0.0%	27,259	12/31/2019